Lundbeck expands the agreement with Teva to include marketing of Azilect in selected Asian countries
26-Feb-2010 -
H. Lundbeck A/S announced it had expanded the agreement with Teva Pharmaceutical Industries Ltd. for Azilect® to cover six markets in Asia - China, South Korea, Hong Kong, Malaysia, Thailand and the Philippines.
The Asian market is becoming an increasingly important platform for Lundbeck, as ...
China
clinical trials
Lundbeck
+6